Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Apr 11;4(5):305–317. doi: 10.1002/acn3.407

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2017 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association.

This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

PMC Copyright notice

ALS patient behavioral data stratified by King's stage, and trichotomized by behavioral severity. ALS patients were classified by the King's staging criteria as follows: Stage 1, 21%; Stage 2, 18%; Stage 3 14%; Stage 4, 47%. In Stage 1, 77% had no behavioral change (1.84 ± 2.0), 13% were in the mild‐moderate change category (9.37 ± 3.46), and 10% were in the clinically severe range (39.50 ± 14.57); Stage 2, 67% of patients had no behavioral change (1.63 ± 1.93), 24% had mild‐moderate behavioral change (11.41 ± 4.92), and 8% were within the clinically severe range (35.50 ± 12.34); Stage 3 patients recorded mostly no behavioral change (50%: 2.1 ± 2.22), with 32% in the mild‐moderate range (12.38 ± 4.83), and 18% (36.28 ± 11.78) in the clinically severe range; Stage 4, 46% of the cohort has no behavioral change (2.93 ± 2.09), 40% exhibited mild‐moderate behavioral change (13.34 ± 4.48), with 14% within the clinically severe range (33.57 ± 12.64).